发明授权
- 专利标题： Amide substituted imidazoquinolines
- 专利标题（中）： 酰胺取代的咪唑并喹啉
-
申请号： US10848893申请日： 2004-05-19
-
公开(公告)号： US07393859B2公开(公告)日： 2008-07-01
- 发明人: Patrick L. Coleman , Stephen L. Crooks , George W. Griesgraber , Kyle J. Lindstrom , Bryon A. Merrill , Michael J. Rice
- 申请人： Patrick L. Coleman , Stephen L. Crooks , George W. Griesgraber , Kyle J. Lindstrom , Bryon A. Merrill , Michael J. Rice
- 申请人地址： US MA Wellesley
- 专利权人： Coley Pharmaceutical Group, Inc.
- 当前专利权人： Coley Pharmaceutical Group, Inc.
- 当前专利权人地址： US MA Wellesley
- 代理机构： Wolf, Greenfield & Sacks, PC
- 主分类号： A61K31/437
- IPC分类号： A61K31/437 ; C07D471/02
摘要：
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
公开/授权文献
- US20040229897A1 Amide substituted imidazoquinolines 公开/授权日：2004-11-18
信息查询
IPC分类:
